clinical trial · NCT06286033
Single and Multiple Ascending Dose Study and Food Effect Study for AG181
Healthy VolunteersAG-181Placebo
brief summary
The primary purpose of this study is to assess the safety and tolerability of AG-181 in healthy participants after oral administration of single ascending dose (SAD) of AG-181 in Part 1 and multiple ascending dose (MAD) in Part 2 along with the effect of food on the pharmacokinetics (PK) of single oral doses of AG-181 in healthy participants in Part 3.
started
Feb 20, 2024
primary completion
Oct 9, 2025
completion
Oct 9, 2025
last updated
Dec 23, 2025
official title
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AG-181 in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol